Novartis Completes Tender Offer for All Outstanding Shares in the Medicines Company
06 Gennaio 2020 - 7:56AM
Dow Jones News
By Giulia Petroni
Novartis AG (NOVN.EB) said Monday that its subsidiary Medusa
Merger Corp. has successfully completed the tender offer for all
outstanding shares of Medicines Co. (MDCO) for a price of $85 a
share.
The Swiss drug giant said that the offer ended on Jan.3 and
approximately 75% of the outstanding shares of the Medicines Co.'s
common stock were validly tendered and not withdrawn, with roughly
an additional 16.9% being offered.
As a result of the merger, The Medicines Company's stock will
cease to be traded on the Nasdaq, according to Novartis.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
January 06, 2020 01:41 ET (06:41 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Novartis (NYSE:NVS)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Novartis (NYSE:NVS)
Storico
Da Apr 2023 a Apr 2024